Opioid Use in Pregnancy: Neurobiological and Clinical Effects on Mothers and Their Children

Abstract

It is crucial to recognize that several medications currently used in hospitals have significant drawbacks. For instance, opioids, while commonly administered to patients, can lead to addiction in some cases. Pregnant women are particularly vulnerable to opioid use disorder, increasing the risk of overdose. The neurobiological impact of opioids on pregnant women remains a relatively underexplored area. Whether obtained through prescription or illicit means, opioids can profoundly affect a patient's brain. The opioids administered during childbirth can be habit-forming, potentially resulting in opioid use disorder (OUD). If a patient misuses drugs due to this disorder, they are likely to experience various side effects resulting from the activation of opioid receptors in the brain. Pregnant women face a heightened risk due to carrying a child, who is also susceptible to the effects of opioids while in the womb. Opioid replacement therapy, typically involving drugs like buprenorphine and methadone, is used to mitigate opioid addiction, but these medications can also impact both the patient and their child. This research aims to shed light on the effects of opioids on pregnant women and raise awareness about the issue of overprescription. Hospitals should avoid overprescribing medications unless necessary to prevent patients from developing OUD. Drawing from multiple sources discussing opioid overdose in pregnant women, this paper delves into the neurobiological effects and their manifestation in physical symptoms. Finally, this paper underscores the importance of thoroughly evaluating the patient's condition before administering medications like buprenorphine and methadone to avoid further harm.